Technology, Healthcare Mar 13, 2022 03:58 PM (GMT+8) · EqualOcean
Warner pharmaceutical announced that the company has received the notice of approval for supplementary drug application for mycophenolate mofetil capsules approved and issued by the State Drug Administration. The drug mycophenolate mofetil capsule was evaluated by the consistency of quality and efficacy of generic drugs. The application of mycophenolate mofetil capsule together with corticosteroids, cyclosporine or tacrolimus is suitable for the treatment of patients receiving allogeneic kidney transplantation and liver transplantation, the prevention of organ rejection, and the induction and maintenance treatment of patients with type III-V adult lupus nephritis.
Related companies: